Daily Download

ISR2.jpg

Injection Site Reactions

Jack Cush, MD
ISRs are common with biologic use
Total%20Biosimilars.Updated.1219.jpg

Even More Biosimilars

Jack Cush, MD
Updated Biosimilars in the US: 11 TNFi and 2 RTX biosimilars
NPQ.jpg

New Patient Intake/Survey Form

Jack Cush, MD
AOSD.ACR_.MTP_.2019.jpg

Adult Stills Disease & Febrile Disorders

Jack Cush, MD
Slide set on Febrile Disorders and AOSD from ACR19
Biosimilars.Updated.1119.jpg

New Biosimilars for Rheumatology - 2019

Jack Cush, MD
4 Slides Reviewing 11 Biosimilars Approved and Indications
Adverse%20Effects%20new%20agents%20Oct%202019.Cush_.jpg

Adverse Effects of Newer Agents 2019

Jack Cush, MD
Safety of Biologics and JAKS - KRA 2019 Presentation
ISR.jpg

Biologic Injection Site Reactions

Jack Cush, MD
ISRs Related to IL-1 inhibitors and TNF inhibitors
RF%2CCCP.Rules__0.jpg

RF/CCP Rules for Use

Jack Cush, MD
New.Biosimilars.0719.jpg

anti-TNF Biosimilars in USA

Jack Cush, MD
UPDATED - there are now 9 biosimilar versions of TNF inhibitors
Screen%20Shot%202019-07-08%20at%202.57.04%20PM.png

RA and Comorbidities

Tammy J. Tilley
3EFAE286-B1EE-442D-8AD1-FEF46F88B9E2.jpeg

Vaccination Deficit in Rheumatology

Tammy J. Tilley
Rhupus.jpg

Comparison of Rhupus and RA

Jack Cush, MD
×